SCHEDULE 13G/AAccepted Aug 13, 11:32 AM ET
Acrivon Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
11:32 AM
Aug 13, 2026
Filed
Aug 13, 2026
Documents
2
Size
17.4 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.